Stryker Corp. (SYK): Price and Financial Metrics
SYK Price/Volume Stats
Current price | $285.28 | 52-week high | $306.93 |
Prev. close | $284.45 | 52-week low | $200.80 |
Day low | $283.40 | Volume | 953,373 |
Day high | $287.73 | Avg. volume | 1,290,618 |
50-day MA | $286.34 | Dividend yield | 1.02% |
200-day MA | $277.20 | Market Cap | 108.34B |
SYK Stock Price Chart Interactive Chart >
SYK POWR Grades
- Sentiment is the dimension where SYK ranks best; there it ranks ahead of 89.22% of US stocks.
- The strongest trend for SYK is in Growth, which has been heading down over the past 179 days.
- SYK's current lowest rank is in the Momentum metric (where it is better than 21.33% of US stocks).
SYK Stock Summary
- With a market capitalization of $111,358,586,968, STRYKER CORP has a greater market value than 98.09% of US stocks.
- SYK's went public 35.66 years ago, making it older than 89.84% of listed US stocks we're tracking.
- Price to trailing twelve month operating cash flow for SYK is currently 36.81, higher than 89.27% of US stocks with positive operating cash flow.
- Stocks with similar financial metrics, market capitalization, and price volatility to STRYKER CORP are GE, ETN, ZTS, IBM, and HON.
- SYK's SEC filings can be seen here. And to visit STRYKER CORP's official web site, go to www.stryker.com.
SYK Valuation Summary
- In comparison to the median Healthcare stock, SYK's EV/EBIT ratio is 214.52% higher, now standing at 39.
- Over the past 243 months, SYK's price/sales ratio has gone up 1.1.
Below are key valuation metrics over time for SYK.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
SYK | 2023-09-18 | 5.7 | 6.4 | 41.1 | 39.0 |
SYK | 2023-09-15 | 5.7 | 6.4 | 41.0 | 38.9 |
SYK | 2023-09-14 | 5.8 | 6.5 | 41.4 | 39.2 |
SYK | 2023-09-13 | 5.8 | 6.5 | 41.7 | 39.4 |
SYK | 2023-09-12 | 5.8 | 6.4 | 41.3 | 39.1 |
SYK | 2023-09-11 | 5.9 | 6.6 | 42.0 | 39.7 |
SYK Growth Metrics
- Its year over year revenue growth rate is now at 18.44%.
- Its 2 year cash and equivalents growth rate is now at -63.22%.
- Its 2 year net cashflow from operations growth rate is now at 22.07%.

The table below shows SYK's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 18,449 | 2,624 | 2,358 |
2022-09-30 | 17,948 | 2,621 | 2,457 |
2022-06-30 | 17,629 | 2,665 | 2,079 |
2022-03-31 | 17,430 | 3,014 | 2,015 |
2021-12-31 | 17,108 | 3,263 | 1,994 |
2021-09-30 | 16,669 | 3,500 | 1,900 |
SYK's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SYK has a Quality Grade of C, ranking ahead of 70.62% of graded US stocks.
- SYK's asset turnover comes in at 0.492 -- ranking 96th of 186 Medical Equipment stocks.
- ISRG, ABMD, and BSX are the stocks whose asset turnover ratios are most correlated with SYK.
The table below shows SYK's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.492 | 0.638 | 0.100 |
2021-06-30 | 0.486 | 0.644 | 0.114 |
2021-03-31 | 0.447 | 0.628 | 0.081 |
2020-12-31 | 0.450 | 0.631 | 0.096 |
2020-09-30 | 0.461 | 0.636 | 0.113 |
2020-06-30 | 0.478 | 0.633 | 0.108 |
SYK Price Target
For more insight on analysts targets of SYK, see our SYK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $287.72 | Average Broker Recommendation | 1.6 (Moderate Buy) |
Stryker Corp. (SYK) Company Bio
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. (Source:Wikipedia)
Latest SYK News From Around the Web
Below are the latest news stories about STRYKER CORP that investors may wish to consider to help them evaluate SYK as an investment opportunity.
Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with BunionsKALAMAZOO, Mich., September 19, 2023--Stryker launched its PROstep® MIS Lapidus, a new minimally invasive surgical option for treating patients with bunions. |
If You Invested $1000 in Stryker a Decade Ago, This is How Much It'd Be Worth NowHolding on to popular or trending stocks for the long-term can make your portfolio a winner. |
The Zacks Analyst Blog Highlights NVIDIA, Advanced Micro Devices, Stryker, Canadian National Railway and TargetNVIDIA, Advanced Micro Devices, Stryker, Canadian National Railway and Target are part of the Zacks top Analyst Blog. |
Top Research Reports for NVIDIA, AMD, Stryker & OthersToday's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Advanced Micro Devices, Inc. (AMD) and Stryker Corporation (SYK). |
Stryker's (SYK) New Camera Platform to Improve Surgery OutcomesStryker's (SYK) latest camera platform is likely to enhance the surgical experience across specialties. |
SYK Price Returns
1-mo | 3.38% |
3-mo | -3.99% |
6-mo | 3.64% |
1-year | 38.18% |
3-year | 45.00% |
5-year | 72.98% |
YTD | 17.29% |
2022 | -7.42% |
2021 | 10.22% |
2020 | 18.17% |
2019 | 35.33% |
2018 | 2.43% |
SYK Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching SYK
Want to do more research on Stryker Corp's stock and its price? Try the links below:Stryker Corp (SYK) Stock Price | Nasdaq
Stryker Corp (SYK) Stock Quote, History and News - Yahoo Finance
Stryker Corp (SYK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...